ACE and COVID-19: One of these pathways is the renin–angiotensin system (RAS) signaling pathway via suppression of the angiotensin I-converting enzyme (ACE), which may help COVID-19 patients experience less tissue damage (Valenzuela et al., 2021; Oh et al., 2021).